Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology
Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBri...
OncoAlert Colloquium Day 1: Genitourinary cancers and geriatric oncology ( Dr Toni Choueiri, Dr Andrea Apolo, Dr Neeraj Agarwal, Dr Piet Ost, Dr Sean McBride, Dr Ravindran Kanesvaran & Dr Nicolo Battisti )
19 Jan 2022
The only Journey is the one within
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
The only Journey is the one within ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Art and medicine
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Art and medicine ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Empathy in cancer care
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Empathy in cancer care ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Teamwork in cancer care
Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Teamwork in cancer care ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
13 Jan 2022
Dihydropyrimidine dehydrogenase polymorphisms knocking on the door
Dr Mauro Daniel Donadio - AC Camargo Cancer Center, Sao Paulo, Brazil
Dihydropyrimidine dehydrogenase polymorphisms knocking on the door ( Dr Mauro Daniel Donadio - AC Camargo Cancer Center, Sao Paulo, Brazil )
11 Jan 2022
Social distancing and economic crisis in Latin America during the COVID-19 pande...
Prof Richard Sullivan and Prof Bettina Müller
Social distancing and economic crisis in Latin America during the COVID-19 pandemic ( Prof Richard Sullivan and Prof Bettina Müller )
10 Jan 2022
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy...
Prof Pamela Allen - Emory University School of Medicine, Georgia, USA
Frontline treatment with single agent pembrolizumab followed by AVD chemotherapy for classic Hodgkin lymphoma ( Prof Pamela Allen - Emory University School of Medicine, Georgia, USA )
22 Dec 2021
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC
Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
22 Dec 2021
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgr...
Dr Sara Hurvitz - University of California, Los Angeles, USA
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ( Dr Sara Hurvitz - University of California, Los Angeles, USA )
21 Dec 2021
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + tr...
Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease ( Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Dec 2021
Efficacy and safety of selinexor in patients with myelofibrosis refractory or in...
Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA
Efficacy and safety of selinexor in patients with myelofibrosis refractory or intolerant to JAK inhibitors ( Prof Srinivas Tantravahi - University of Utah, Salt Lake City, USA )
20 Dec 2021